UK's NICE launches two on-line databases

18 December 2006

The National Institute for Health and Clinical Excellence (NICE), the UK advisory body responsible for evaluating the effectiveness of drugs and clinical treatments in England and Wales, has launched two new on-line databases which it claims will "support the implementation of guidance."

The first database is called Shared Learning and contains examples of local implementation projects across the National Health Service and other government-funded health care programs. As the name implies, its objective is to enable the spread of good practices across the UK. The database can be accessed via the Internet at: www.nice.org.uk/sharedlearning.

The second database is the evaluation and review of NICE implementation evidence available at: www.nice.org.uk/ernie. According to the NICE, ERNIE "provides a bank of guidance-specific implementation uptake reports produced by NICE and references to external studies looking at how [the] NICE guidance is being implemented." External studies are categorized according to whether the NICE's guidance is being correctly implemented, offering the following graduations: practice appears to be in line with guidance; doubts about or mixed impact in practice; and not graded, insufficient evidence to make assessment.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight